Acelyrin, Inc. (SLRN)
Total Valuation
Acelyrin has a market cap or net worth of $657.04 million. The enterprise value is -$130.14 million.
Market Cap | 657.04M |
Enterprise Value | -130.14M |
Important Dates
The next estimated earnings date is Tuesday, April 9, 2024, before market open.
Earnings Date | Apr 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Acelyrin has 97.34 million shares outstanding. The number of shares has increased by 5,390.74% in one year.
Shares Outstanding | 97.34M |
Shares Change (YoY) | +5,390.74% |
Shares Change (QoQ) | +48.55% |
Owned by Insiders (%) | 20.59% |
Owned by Institutions (%) | 91.28% |
Float | 62.91M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.90 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.89, with a Debt / Equity ratio of 0.00.
Current Ratio | 11.89 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$6.00M |
Employee Count | 51 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 7.66 |
200-Day Moving Average | 13.07 |
Relative Strength Index (RSI) | 38.33 |
Average Volume (30 Days) | 1,263,442 |
Short Selling Information
The latest short interest is 8.41 million, so 8.64% of the outstanding shares have been sold short.
Short Interest | 8.41M |
Short Previous Month | 6.93M |
Short % of Shares Out | 8.64% |
Short % of Float | 13.37% |
Short Ratio (days to cover) | 6.79 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | -306.24M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$5.06 |
Balance Sheet
The company has $788.43 million in cash and $1.25 million in debt, giving a net cash position of $787.18 million or $8.09 per share.
Cash & Cash Equivalents | 788.43M |
Total Debt | 1.25M |
Net Cash | 787.18M |
Net Cash Per Share | $8.09 |
Equity / Book Value | 732.38M |
Book Value Per Share | 7.52 |
Working Capital | 727.78M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Acelyrin does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5,390.74% |
Shareholder Yield | -5,390.74% |
Earnings Yield | -46.61% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Acelyrin is $24.00, which is 255.56% higher than the current price. The consensus rating is "Buy".
Price Target | $24.00 |
Price Target Difference | 255.56% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -45.53% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |